Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

Increasing Doses of Pentoxifylline as a Continuous Infusion in Canine Septic Shock

Zenaide M. N. Quezado, William D. Hoffman, Steven M. Banks, Robert L. Danner, Peter Q. Eichacker, Gregory M. Susla and Charles Natanson
Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 107-113;
Zenaide M. N. Quezado
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William D. Hoffman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven M. Banks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert L. Danner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Q. Eichacker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory M. Susla
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Natanson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

We investigated effects of pentoxifylline during septic shock. Two-year-old (10–12 kg), purpose-bred beagles were infected i.p. withEscherichia coli 0111:B4 (1.2–1.5 × 109 colony-forming units per kilogram b.wt.) in a fibrin clot and then immediately treated with one of five doses of pentoxifylline (0.5–20 mg · kg−1 · h−1 i.v.) as a 36-h continuous infusion or placebo. All animals received antibiotics and fluid resuscitation. Pentoxifylline levels increased in a dose-dependent manner during (p = .001) and were undetectable 12 h after stopping the infusion. During infusion of pentoxifylline at all doses, there were increases (p = .003), and once the infusion was stopped, there were decreases (p = .049) in endotoxin levels compared with controls. After clot implantation, at all pentoxifylline doses there was a significant increase in tumor necrosis factor levels, compared with controls (p = .025). The relative risk of death was significantly increased with pentoxifylline therapy in a dose-dependent fashion (20 ≥ 10 ≥ 5.0 ≥ 1.0 ≥ 0.5 mg · kg−1, p = .008). One hypothesis consistent with these data is that high pentoxifylline levels slowed endotoxin clearance, resulting in high levels of endotoxemia and increased proinflammatory mediator release and death. Pentoxifylline, used as a long-term continuous infusion as is commonly done clinically, can be harmful during Gram-negative septic shock.

Footnotes

  • Send reprint requests to: Dr. Charles Natanson, Critical Care Medicine Department, National Institutes of Health, Building 10, Room 7D43, 9000 Rockville Pike, Bethesda, MD 20892.

  • ↵1 Preliminary data were published in abstract form in Quezado ZMN, Natanson C, Banks SM, Koev CA, Danner RL, Elin RJ, Hosseini JM, Bacher JD and Hoffman WD (1993) Pentoxifylline can increase tumor necrosis factor level and decrease survival in a canine model of Gram negative septic shock (abstract). Crit Care Med21:S281.

  • Abbreviations:
    CFU
    colony-forming units
    TNF
    tumor necrosis factor
    ANOVA
    analysis of variance
    • Received April 17, 1998.
    • Accepted July 30, 1998.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 288 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 288, Issue 1
1 Jan 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Increasing Doses of Pentoxifylline as a Continuous Infusion in Canine Septic Shock
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Increasing Doses of Pentoxifylline as a Continuous Infusion in Canine Septic Shock

Zenaide M. N. Quezado, William D. Hoffman, Steven M. Banks, Robert L. Danner, Peter Q. Eichacker, Gregory M. Susla and Charles Natanson
Journal of Pharmacology and Experimental Therapeutics January 1, 1999, 288 (1) 107-113;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Increasing Doses of Pentoxifylline as a Continuous Infusion in Canine Septic Shock

Zenaide M. N. Quezado, William D. Hoffman, Steven M. Banks, Robert L. Danner, Peter Q. Eichacker, Gregory M. Susla and Charles Natanson
Journal of Pharmacology and Experimental Therapeutics January 1, 1999, 288 (1) 107-113;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism
  • Discriminative Stimulus Effects of Zolpidem in Squirrel Monkeys: Comparison with Conventional Benzodiazepines and Sedative-Hypnotics
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics